Log In
Print this Print this

EMD 1201081, IMO-2055

Also known as: IMOxine (HYB2055) (formerly IMO2055)

  Manage Alerts
Collapse Summary General Information
Company Idera Pharmaceuticals Inc.
DescriptionSecond-generation synthetic immune modulatory oligonucleotide (IMO) agonist of toll-like receptor 9 (TLR9)
Molecular Target Toll-like receptor 9 (TLR9)
Mechanism of ActionToll-like receptor 9 (TLR9) agonist
Therapeutic ModalityNucleic acid: Linear DNA

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today